Medicare GLP-1 Coverage in 2026: How to Qualify for Wegovy and Zepbound

Updated: April 2026

If you have been watching the price tag on Wegovy or Zepbound and thinking “there is no way Medicare covers that” — the rules just changed. Starting July 1, 2026, Medicare is rolling out a new program that covers FDA-approved GLP-1 weight loss drugs for qualifying seniors. For the first time ever, beneficiaries who meet specific health criteria can access these $1,300/month medications for just $50 out of pocket.

Here is exactly who qualifies, what is covered, and the steps to take before July.

What Is the Medicare GLP-1 Bridge Program?

The Medicare GLP-1 Bridge is a temporary federal demonstration program announced by the Centers for Medicare and Medicaid Services (CMS) on December 23, 2025. It runs from July 1 through December 31, 2026, and serves as a bridge until the broader BALANCE Model (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) takes effect in January 2027.

The program covers two specific GLP-1 receptor agonist medications approved for chronic weight management:

• Wegovy® (semaglutide 2.4 mg) — all formulations
• Zepbound® / Foundayo® (tirzepatide) — KwikPen® formulation

Important: Ozempic is not included in this program for weight loss. Medicare Part D already covers Ozempic for Type 2 diabetes — that has not changed. Full details at the official CMS Medicare GLP-1 Bridge page.

Who Qualifies? The Eligibility Requirements

This is where a lot of people get tripped up. Medicare is not automatically covering GLP-1 drugs for everyone with obesity — there are specific clinical criteria, and your doctor has to formally attest to them via prior authorization.

To qualify, you must meet all three of the following conditions:

1. Medicare Part D Enrollment

You must be enrolled in a standalone Medicare Part D prescription drug plan, or a Medicare Advantage plan that includes drug coverage (MA-PD). Original Medicare (Parts A and B only) does not cover prescription drugs and will not qualify for this program.

2. BMI of 30 or Higher

You need a documented body mass index (BMI) of 30+, which is the clinical threshold for obesity. A BMI of 27+ may also qualify if accompanied by a weight-related health condition — your doctor will confirm this during your prior authorization request.

3. An Obesity-Related Cardiovascular Condition

This is the key eligibility gate. CMS’s March 2026 final rule requires at least one documented obesity-related cardiovascular condition, such as:

• Hypertension (high blood pressure)
• Type 2 diabetes
• A prior major adverse cardiac event (heart attack or stroke)
• Dyslipidemia (abnormal cholesterol levels)

If you have obesity and one of these conditions, you are likely in the qualifying range. Check with your primary care physician — they will review your chart and determine if you meet CMS criteria.

How Much Will It Cost?

This is honestly the most striking part of the program. Wegovy has a list price of roughly $1,349 per month without insurance. Under the Medicare GLP-1 Bridge, eligible beneficiaries pay a flat $50 per month.

What makes this especially valuable:

• The $50 copay does not count toward your Part D deductible.
• It does not count toward the $2,100 annual out-of-pocket maximum.
• The $50 stays flat regardless of which Part D benefit phase you are in when you fill the prescription.

Step-by-Step: How to Get GLP-1 Coverage Through Medicare

Step 1: Confirm Your Medicare Part D Enrollment

Log in to Medicare.gov or call 1-800-633-4227 to verify you are enrolled in a Part D or MA-PD plan for 2026. If you are on Original Medicare only, you will need to enroll in Part D — check enrollment periods and late penalties before you act.

Step 2: Schedule an Appointment with Your Primary Care Doctor

Before July 1, visit your doctor to discuss weight management. Bring your current conditions list, medications, and recent lab work — A1C levels, lipid panels, and blood pressure readings are especially relevant. Your doctor needs to document that you meet the BMI and cardiovascular criteria in your medical chart.

Step 3: Request Prior Authorization

Your doctor’s office submits a prior authorization (PA) request to your Medicare plan. This formally attests you meet CMS eligibility criteria. The process typically takes 3–10 business days. If denied, you have the right to appeal — your doctor’s office or your state’s SHIP counseling program can help guide you.

Step 4: Fill Your Prescription Starting July 1

Once approved, fill a Wegovy or Zepbound prescription at any in-network pharmacy on or after July 1, 2026. You pay $50. Keep your prior authorization approval number on hand in case of any pharmacy issues.

Step 5: Plan for the BALANCE Model Transition (Jan 2027)

The Bridge runs through December 31, 2026. The BALANCE Model starts January 1, 2027 with negotiated pricing. Staying on the drug through the bridge period sets you up for a smoother transition — discuss continuity of care with your doctor heading into 2027.

Common Mistakes to Avoid

• Assuming your plan automatically participates. Participation in the GLP-1 Bridge is voluntary for Part D plans. Call your plan before July to confirm.
• Waiting until July to talk to your doctor. Prior authorizations take time. Start the conversation now so the PA is ready for July 1.
• Confusing Ozempic with Wegovy. Same active ingredient, different doses and covered indications. Ozempic for diabetes is covered separately. Wegovy for obesity is covered under this Bridge. Not interchangeable under this program.
• Thinking the $50 copay counts toward your deductible. It does not. The $50 is a flat rate outside normal Part D cost-sharing — which is actually better for you.

How Many Seniors Could Qualify?

CMS estimates approximately 3.4 million Medicare beneficiaries could be eligible for the GLP-1 Bridge based on current obesity and cardiovascular data. The Kaiser Family Foundation has published detailed analysis at KFF.org on what this means for beneficiaries.

Frequently Asked Questions

Bottom Line

For the first time in Medicare’s history, weight loss GLP-1 medications are covered at a price most seniors can afford. If you have a BMI of 30+ and a cardiovascular condition like hypertension or Type 2 diabetes, you are very likely in the qualifying pool for Wegovy or Zepbound at $50/month starting July 1, 2026.

The window between now and July is your prep time. Confirm your Part D enrollment, get an appointment with your doctor, and start prior authorization early. Do not wait until July 2 to discover you needed paperwork done in May.

For official enrollment details, visit Medicare.gov or call 1-800-633-4227.

Explore more guides at HowToCore.